Galicia Launches Xenoma Project, a Pioneer in Personalized Medicine
Galicia Launches Groundbreaking genomic Project to Revolutionize Healthcare
Santiago de Compostela,Spain – Galicia is taking a giant leap forward in personalized medicine with the launch of Xenoma Galicia,a pioneering project aimed at mapping the genomes of 400,000 Galicians.
President of the Xunta,Alfonso Rueda,marked the project’s commencement on Saturday at the Santiago de Compostela University Clinical Hospital,witnessing the first blood sample collection.
“This is an example of modern,future-focused medicine already being practiced in Galicia,” rueda emphasized.
over the coming weeks, the initiative will expand to all 14 Galician hospitals. In this initial phase, participants from 15 municipalities will contribute blood samples, with an additional 1,000 saliva samples to be collected in 2025.
Targeting Disease Prevention Through Genetic Insights
Xenoma Galicia focuses on collecting DNA from Galicians aged 35 to 70, representing one in seven inhabitants. The goal is to identify high-risk genetic variants associated with diseases like hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia.
This proactive approach allows for early intervention, personalized treatments, and significantly improved disease prevention.
Building a Genomic Database for Future Research
Beyond immediate healthcare benefits, Xenoma Galicia aims to establish a thorough biobank containing genomic data from 100,000 individuals. This valuable resource will fuel future biosanitary research, positioning Galicia as a leader in genetic innovation.
Galicia at the Forefront of Personalized Medicine
Rueda highlighted Galicia’s commitment to cutting-edge healthcare, citing advancements like the proton therapy center scheduled to open in 2026 and the existing CAR-T therapy center. He also pointed to Galicia’s leading role in preventative care, including Spain’s most advanced neonatal screening program, comprehensive cancer screening initiatives, and a vaccination schedule considered the most complete globally.
Led by Dr. Ángel Carracedo,director of the Public Foundation of Genomic Medicine,Xenoma Galicia underscores Galicia’s dedication to healthcare innovation.
“This demonstrates the excellence and daily work of our public health system, making initiatives like this a reality,” Rueda concluded.
Attracting Talent and Fostering Innovation
Beyond it’s direct impact on healthcare, Xenoma Galicia aspires to establish Santiago de Compostela and Galicia as hubs for genomic research and innovation. By strengthening the research ecosystem and attracting top talent, the project aims to solidify Galicia’s position as a global leader in personalized medicine.
[Image: A scientist examining DNA samples in a laboratory.]
xenoma Galicia: decoding Health Through Genetics
Newsdirectory3.com – In a groundbreaking move toward personalized medicine,Galicia has embarked on the ambitious Xenoma Galicia project,which will map the genomes of 400,000 Galicians. Launched by the President of the Xunta, Alfonso Rueda, the project will collect blood and saliva samples from individuals aged 35 to 70 across all 14 Galician hospitals.
This revolutionary initiative aims to identify genetic variants linked to diseases such as hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia, enabling early intervention and personalized treatments for participants.
“xenoma Galicia is an example of modern, future-focused medicine already being practiced in Galicia,” stated President Rueda.
The collected data will not only benefit individual participants but will also create a comprehensive biobank containing genomic data from 100,000 individuals, paving the way for future biosanitary research and positioning Galicia at the forefront of genetic innovation.
Xenoma Galicia is the latest in a series of healthcare advancements in galicia, highlighting the region’s commitment to cutting-edge medicine. This includes a proton therapy center scheduled to open in 2026, an existing CAR-T therapy center, and Spain’s most advanced neonatal screening program.
led by Dr.Ángel Carracedo, Director of the Public Foundation of Genomic Medicine, Xenoma Galicia signifies Galicia’s dedication to healthcare innovation.”This demonstrates the excellence and daily work of our public health system, making initiatives like this a reality,” President Rueda concluded.
by attracting top talent and fostering a thriving research ecosystem, Xenoma Galicia aims to establish Santiago de Compostela and Galicia as global hubs for genomic research and innovation.